Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials

…, A Tsapas, C Loutradis, A Boutou… - Journal of …, 2019 - journals.lww.com
Background: Reductions in albuminuria of more than 30% are considered a strong marker
of delay of chronic kidney disease (CKD) progression. Single renin–angiotensin system (RAS…

[HTML][HTML] COVID-19 and liver injury: An ongoing challenge

…, DG Spyratos, K Porpodis, AK Boutou… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The new coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
identified in December 2019, in Wuhan, China. The virus was rapidly spread worldwide, …

[HTML][HTML] Long COVID-19 pulmonary sequelae and management considerations

AK Boutou, A Asimakos, E Kortianou… - Journal of Personalized …, 2021 - mdpi.com
The human coronavirus 2019 disease (COVID-19) and the associated acute respiratory
distress syndrome (ARDS) are responsible for the worst global health crisis of the last century. …

Lung function indices for predicting mortality in COPD

AK Boutou, D Shrikrishna, RJ Tanner… - European …, 2013 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is characterised by high morbidity and
mortality. It remains unknown which aspect of lung function carries the most prognostic …

Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses

AK Boutou, I Stanopoulos, GG Pitsiou, T Kontakiotis… - Respiration, 2011 - karger.com
Background: Anemia may be present in patients with chronic obstructive pulmonary disease
(COPD) and further impair their functional capacity. Objectives: This study investigated the …

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension

AK Boutou, GG Pitsiou, I Trigonis, D Papakosta… - …, 2011 - Wiley Online Library
Background and objective: Increased pulmonary arterial pressure (PAP) usually coexists
with impaired lung function in IPF. Data on the effect of pulmonary hypertension (PH) on …

An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD

AK Boutou, RJ Tanner, VM Lord… - BMJ open …, 2014 - bmjopenrespres.bmj.com
Background Pulmonary Rehabilitation (PR) is an important treatment for patients with
chronic obstructive pulmonary disease (COPD) but it is not established whether any baseline …

[HTML][HTML] Persistent sleep quality deterioration among post-COVID-19 patients: results from a 6-month follow-up study

E Kalamara, A Pataka, A Boutou… - Journal of Personalized …, 2022 - mdpi.com
Background: To date, evidence about sleep disturbances among post-COVID-19 patients is
limited. This study aimed to evaluate sleep quality after hospitalization due to SARS-CoV-2 …

Mycobacterium avium complex infection in non‐cystic fibrosis bronchiectasis

Z Zoumot, AK Boutou, SS Gill, M Van Zeller… - …, 2014 - Wiley Online Library
Background and objective Reliable markers of disease progression or stability to assist in
management decisions are lacking in patients with non‐cystic fibrosis bronchiectasis and …

Redefining cut-points for high symptom burden of the global initiative for chronic obstructive lung disease classification in 18,577 patients with chronic obstructive …

…, A Agusti, NB Atalay, J Billington, AK Boutou… - Journal of the American …, 2017 - Elsevier
Background Patients with chronic obstructive pulmonary disease (COPD) can be classified
into groups A/C or B/D based on symptom intensity. Different threshold values for symptom …